Obalon Therapeutics, Inc.

Dexcom, Inc.

Reshape Lifesciences Inc.

Antonio C Llevares

Mark C Brister

Neil R Drake

Andrew P Rasdal

Amy D L VandenBerg

Dubravka Markovic

Kaushik Aroonkumar Patel

Nelson Quintana

Matthew S Lake

Josefina Nider

Paul D Faucher

Peter C Simpson

Jack Pryor

Robert James Boock

Paul V Neale

Matthew D Wightlin

Jeff Jackson

Jason Mitchell

Michael Robert Mensinger

Sebastian Bohm

Richard Chien Yang

John Michael Dobbles

Betty Wong

Daniel J Proctor

Sheldon Nelson

Keoni John Sundseth

Amy Dl VandenBerg

Sebastian Böhm

Eleanor McCarthy

Dubravka Markvoic

Amy D I Vandenberg

Amy DL Vandenberg

Amy D L Vandenberg

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Intragastric device

Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor systemcomprising two working electrodes and at least one reference/counter electrode is provided. The sensor systemcomprises first and second elongated bodies E, E, each formed of a conductive core or of a core with a conductive layer deposited thereon, insulating layerthat separates the conductive layerfrom the elongated body, a membrane layer deposited on top of the elongated bodies E, E, and working electrodes″ formed by removing portions of the conductive layerand the insulating layer, thereby exposing electroactive surface of the elongated bodies E, E

Analyte sensors and methods of manufacturing same

An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

Integrated medicament delivery device for use with continuous analyte sensor

Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.

Intragastric volume-occupying device and method for fabricating same

An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.

Systems and methods for determining failure of intragastric devices

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided. More particularly, apparatuses and methods for enabling volume-occupying intragastric devices to pass through the digestive system are provided.

Systems and methods for enabling passage of an intragastric device

Intragastric device system

Growing community of inventors

Chula Vista, CA, United States of America

Antonio C Llevares